Status:
WITHDRAWN
Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
American Society for Surgery of the Hand
Conditions:
Neuroma
Neuroma Amputation
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to characterize the perfusion of neuromas using indocyanine green fluorescence angiography
Detailed Description
Neuromas represent the frustrated regeneration of injured nerve axons encased in a bulbous scar. Symptomatic neuromas are particularly problematic in patients with amputations. Targeted Muscle Reinner...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Clinical diagnosis of neuroma
- Scheduled elective surgery for neuroma excision
Exclusion
- Minors, or age \< 18 years old at the time of surgery
- Unable to provide written, informed consent
- Prisoners and decision-impaired individuals
- Pregnant or lactating women
- History of allergy to indocyanine green
- History of allergy to iodides
- History of allergic asthma
- History of hepatic failure
- History of renal failure
- Patients in whom the planned surgical incision/approach does not include excision of the neuroma
- Patients in whom adequate surgical exposure of the neuroma is unable to be obtained, as determined intraoperatively at the time of surgery by the Investigator or Co-Investigators
- Any subject who, at the discretion of the Investigator or Co-Investigators, is not suitable for inclusion in the study
Key Trial Info
Start Date :
December 28 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 28 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06164392
Start Date
December 28 2024
End Date
December 28 2024
Last Update
January 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University
Chicago, Illinois, United States, 60657